Z Squared Finalizes Spin-Off Dividend and Nasdaq Trading Under New Ticker ZSQR

summarizeSummary

Z Squared, Inc. (formerly Coeptis Therapeutics) announced the final details and distribution date for its pro rata dividend of Coeptis Holdings, Inc. shares to shareholders of record, coinciding with its Nasdaq trading commencement under the new ticker ZSQR.

check_boxKey Events

• Spin-Off Dividend Details Finalized

  Shareholders of record on January 2, 2026, will receive one non-transferable share of Coeptis Holdings, Inc. common stock for each share held, with the distribution effected on April 27, 2026. This completes the spin-out of the pre-business combination biopharmaceutical business.

• New Ticker Symbol Effective

  The company's common stock commenced trading on the Nasdaq Global Market under the new ticker symbol "ZSQR" on April 27, 2026, following its business combination and rebranding from Coeptis Therapeutics Holdings, Inc.

auto_awesomeAnalysis

This 8-K provides crucial final details regarding the business combination and spin-off that Coeptis Therapeutics Holdings, Inc. (now Z Squared, Inc.) has been undergoing. It confirms the record date and distribution date for the pro rata dividend of Coeptis Holdings, Inc. shares, allowing original shareholders to retain exposure to the biopharmaceutical business. Furthermore, it officially marks the commencement of trading under the new ticker symbol ZSQR on Nasdaq, completing the rebranding and business pivot to a computing infrastructure company. This filing operationalizes key aspects of the transformational merger previously announced, providing clarity and execution details vital for investors.